International randomized, double-blind, placebo-controlled, phase 3 study of linsitinib (OSI-906, L) in patients (pts) with locally advanced or metastatic adrenocortical carcinoma (ACC)
| العنوان: | International randomized, double-blind, placebo-controlled, phase 3 study of linsitinib (OSI-906, L) in patients (pts) with locally advanced or metastatic adrenocortical carcinoma (ACC) |
|---|---|
| المؤلفون: | Martin Fassnacht, Srinivasu Poondru, Michael J. Demeure, Tanya Fleege, Ramona Rorig, Eric Baudin, David I. Quinn, Gary D. Hammer, Alfredo Berruti |
| المصدر: | Journal of Clinical Oncology. 32:4507-4507 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2014. |
| سنة النشر: | 2014 |
| مصطلحات موضوعية: | Oncology, Cancer Research, medicine.medical_specialty, Linsitinib, business.industry, Locally advanced, Metastatic Adrenocortical Carcinoma, Cancer, Phases of clinical research, Placebo, medicine.disease, behavioral disciplines and activities, Surgery, Double blind, stomatognathic diseases, chemistry.chemical_compound, nervous system, chemistry, Internal medicine, medicine, In patient, business, human activities, psychological phenomena and processes |
| الوصف: | 4507 Background: ACC is an uncommon but frequently fatal cancer. For pts with metastatic or recurrent nonoperable ACC, there are very limited treatment options. Insulin-like growth factor 2 (IGF2) ... |
| تدمد: | 1527-7755 0732-183X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::7bcb65ffb6a7be0c00fd843158f6facf https://doi.org/10.1200/jco.2014.32.15_suppl.4507 |
| رقم الأكسشن: | edsair.doi...........7bcb65ffb6a7be0c00fd843158f6facf |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|